|
RPL7L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.38677958005928E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
7.431600E-01 |
| Normal-vs-Stage3 |
4.678600E-01 |
| Normal-vs-Stage4 |
5.555800E-02 |
| Stage1-vs-Stage2 |
2.302200E-01 |
| Stage1-vs-Stage3 |
6.121900E-02 |
| Stage1-vs-Stage4 |
1.686580E-01 |
| Stage2-vs-Stage3 |
9.282000E-01 |
| Stage2-vs-Stage4 |
5.416800E-01 |
| Stage3-vs-Stage4 |
4.366400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.24420054656593E-10 |
| Normal-vs-AfricanAmerican |
9.78780000049362E-07 |
| Normal-vs-Asian |
6.453800E-02 |
| Caucasian-vs-AfricanAmerican |
9.009200E-01 |
| Caucasian-vs-Asian |
8.085600E-01 |
| AfricanAmerican-vs-Asian |
7.096400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8375301280571E-12 |
| Normal-vs-Female |
2.596500E-03 |
| Male-vs-Female |
1.272090E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.45730000476053E-08 |
| Normal-vs-Extreme_Weight |
5.0990001110307E-10 |
| Normal-vs-Obese |
7.792500E-02 |
| Normal-vs-Extreme_Obese |
2.002900E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.215000E-01 |
| Normal_Weight-vs-Obese |
1.387610E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.214200E-01 |
| Extreme_Weight-vs-Obese |
4.532100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.461800E-01 |
| Obese-vs-Extreme_Obese |
4.529900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.209000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.61769494969144E-11 |
| Normal-vs-Age(61-80Yrs) |
5.60320000397851E-08 |
| Normal-vs-Age(81-100Yrs) |
5.24620347164273E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.077800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.211840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.554300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.753600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.383500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.762200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
9.714400E-02 |
| Normal-VS-KIRP CIMP |
5.082200E-01 |
| Normal-VS-Unclassified PRCC |
4.69640000000382E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.586300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.277900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.275400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.085200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.583770E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.672500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.388020E-04 |
| Normal-vs-N1 |
6.025000E-01 |
| Normal-vs-N2 |
3.89410000001256E-06 |
| N0-vs-N1 |
7.618500E-03 |
| N0-vs-N2 |
7.491200E-01 |
| N1-vs-N2 |
1.752370E-01 |
|
|
